Chengguo (CX) Xing

Chengguo (Chris) Xing is a distinguished Professor and Associate Chair in the Department of Medicinal Chemistry at the University of Florida. With a robust academic background, he earned his Ph.D. in organic chemistry from Arizona State University, followed by postdoctoral training in chemical biology at Harvard University. His academic journey has equipped him with a profound understanding of the intricate world of chemistry and its applications in medicine. Professor Xing's research is at the forefront of drug discovery, focusing on the isolation, design, and synthesis of biologically active small molecules. His work aims to develop innovative solutions for managing human diseases, with a particular emphasis on translational development. His team is dedicated to creating novel therapies that are selective against multi-drug resistant malignancies, which pose significant challenges in cancer treatment. In addition to his work on cancer chemotherapy, Xing is deeply invested in chemoprevention, exploring agents that can prevent primary carcinogenesis. His research extends to neurological disorders, where he is investigating natural dietary supplements that could offer therapeutic benefits. This multifaceted approach underscores his commitment to advancing human health through chemistry. Throughout his career, Professor Xing has been recognized for his contributions to the field. He has been honored with several prestigious awards, including the Teacher of the Year Award from the University of Minnesota, highlighting his dedication to education and mentorship. Additionally, he received the Young Investigator Award from the American Association of Colleges of Pharmacy (AACP), acknowledging his innovative research and potential for future contributions. Professor Xing's work continues to inspire both his students and colleagues, as he leads efforts to translate scientific discoveries into practical applications that can improve patient outcomes. His passion for research and teaching makes him a valuable asset to the University of Florida and the broader scientific community.